Brett Drummond 10/9/24 Brett Drummond 10/9/24

Novoron Bioscience Welcomes Dr. David Weiner to the Board of Directors

Novoron Bioscience is excited to announce that Dr. David Weiner is the newest member of the Board of Directors.

Guest User 6/2/24 Guest User 6/2/24

Novoron Bioscience To Present at BIO 2024 Conference

Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, will be participating in a range of activities at the upcoming BIO 2024 conference.

Guest User 1/31/22 Guest User 1/31/22

Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer's Disease

Novoron Bioscience has received an NIH/NIA grant to advance its work on Alzheimer’s disease, CTE and other tauopathies.

Guest User 11/19/21 Guest User 11/19/21

Novoron Bioscience Raises $3M in Seed Financing from Two Bear Capital

Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they secured a $3 million Seed investment from Two Bear Capital (TBC).

Lauren Anderson 9/27/21 Lauren Anderson 9/27/21

Novoron’s History & Milestones

Lauren Anderson 6/1/20 Lauren Anderson 6/1/20

World MS Day 2020: Connecting the Multiple Sclerosis Community

A conversation focussed primarily on the importance of connecting multiple sclerosis (MS) researchers/scientists and people living with MS.